Pharmaceutical Formulation And Development Services

Kemwell's Pharmaceutical Development Unit (PDU), in India and Sweden are led by a strong management team with the necessary experience, scientific knowledge, vision and steadfast commitment to meet each customers' needs.

Formulations are rationally developed to enhance product stability, bioavailability, patient compliance, and ultimately the customers' expectations. Additionally, Kemwell has extensive expertise in Quality by Design (QBD), and can incorporate in your formulation program.

Our scientists approach each formulation project with the commercial product in mind. We integrate process development and scale-up in the process at early stages, minimizing the potential for costly reformulation down the road. Each formulation program will include the development of multiple drug product prototypes. These prototypes are subsequently subjected to demanding conditions, chemical, & physical testing, that ultimately producing an ideal, final drug formulation for our customer.

Planning and preparation, prior to prototype development in involves critical pre-formulation studies. Characterization of the Active Pharmaceutical Ingredient (API) is critical to defining a successful formulation approach. Proper drug substance evaluation at the pre-formulation stage can minimize potential formulation, manufacturing, scale up, & instability issues.

Drug stability profiling during pre-formulation & formulation development, including GRAS excipient compatibility can provide innovative solutions to drug product instabilities and product specifications. At Kemwell, our focus is to deliver a product formulation that is stable when exposed to forces such as temperature, light, and humidity.